International Journal of Technology Assessment in Health Care

Article	Citations
PP114 The Influence Of Implicit Factors On The Health Technology Assessment Deliberative Process: A Survey In Five European Countries	185
PP150 The Role Of Expert Consensus In UK Guidance: Patient Selection For Hydrogel Spacer Use During Prostate Cancer Radiotherapy	43
PP53 Applying The VALIDATE Approach To Frame The Assessment Of Integrated Care Management In Aortic Valve Stenosis	32
PP97 Recommendations For Generating South African Health-Related Quality Of Life Data For Cost-Utility Analyses	28
PD35 Mortality And Risk Factors Associated With Dialysis Patients With COVID-19 In A Brazilian Supplementary Health Service	23
PD09 Comparing Long-term Costs Associated With Intraocular Lens Selection And Nd:YAG Laser Capsulotomy In The UK: A Cost-Consequence Analysis	21
OP92 Impact Of Real-World Evidence On Health Technology Assessment And National Guidance For Interventional Procedures: A UK Perspective	20
OP42 Increasing Access To Real-World Data To Move From Health Technology Assessment To Health Technology Management	20
PP23 Lost In Translation? The Differences In The Use Of Real-World Evidence Across Key Markets	20
OP123 The Use Of Surrogate Outcomes In National Institute For Health And Care Excellence (NICE) Highly Specialised Technology Evaluations: A Review Of Published Guidance	20
PP47 Modelling Non-small Cell Lung Cancer Treatment: Predicted and Observed Impact Of Immunotherapy In The Netherlands	20
OP312 Developing A Tool-kit For Assessment Of Autism Spectrum Disorder	19
PP94 Pandemic Preparedness: EUnetHTA COVID-19 Rapid Response With “Rolling Collaborative Reviews (RCR)”	19
OP82 Positron Emission Tomography Combined With Computed Tomography Using 18F-Sodium Fluoride	18
OP128 Uncertainties In The Cost-Effectiveness Analysis Of Onasemnogene Abeparvovec For Spinal Muscular Atrophy Type 1	17
PP97 How Health Technology Agencies Estimate Target Population Size For Medical Devices: The Example Of Spinal Cord Stimulation	17
PP38 Designing A Training And Capacity Building Pathway In Patient Involvement	15
PP105 Efficacy, Effectiveness And Safety Of Letermovir For Prophylaxis Of Cytomegalovirus Infection And Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation	15
PP79 Publication Trends Of Network Meta-analyses In Europe And Asia: A Focus On Cardiovascular Disease	15
PP11 Patient Involvement In Drug Evaluations To Inform Funding Decisions: A Singapore Case Study	15
OP19 Exploring The Environment/Capacity Of South African Citizen Actors To Contribute To Health Technology Assessment Processes, Policy Development And Institutionalization	13
PD208 Optimal Scheme For Molecular Diagnosis Of BRCA1/2 Gene Mutations In Patients With Breast Cancer In Poland - Cost-Utility Analysis	12
OP60 Methodological Guidance And Doctrine Of The French National Authority For Health For Economic Evaluation	12
PD137 Reviewing The Health Technology Assessment And Regulatory Policy Landscape On Acceptability Standards For Real-World Evidence - Initial Findings	12
Trial-based economic evaluation of the BrainACT study: acceptance and commitment therapy for anxiety and/or depressive symptoms after acquired brain injury	12

PD149 Comparison Of The Draft European Union Health Technology Assessment Template With Germany’s AMNOG Template	11
OP76 Cost-Effectiveness Of Offering Human Papillomavirus Self-Sampling To Non-Attendees Of Organized Primary Cervical Cancer Screening In Germany	11
OP25 Rapid Molecular Tests For Detecting Multidrug-Resistant Microorganisms: An Overview Of Systematic Reviews Within A Living Evidence Project	10
PP07 One Bad Apple Can Spoil The Barrel: Are We Effectively Evaluating Software As A Medical Device?	10
Reframing Early Health Technology Assessment Through a Lifecycle Lens: Commentary on “Defining Early Health Technology Assessment: Building Consensus Using Delphi Technique”	10
PD10 Cost Effectiveness Analysis Of Etranacogene Dezaparvovec Versus Factor IX Prophylaxis In Adult Men With Hemophilia B From Brazil	10
PD129 Extension Of An Influenza Vaccination Program To Include Those Aged 50 To 64 Years: A Rapid Health Technology Assessment Approach	10
PP92 Enhancing Patient Engagement In Health Technology Assessment: Identification Of Barriers, Facilitators, And Proposals For Improvement	10
OD12 Large Language Models As Powerful Tools In Health Technology Assessment	10
PP56 National Immunization Technical Advisory Groups Are Essential For Successful Implementation Of The European Health Technology Assessment Regulation	10
Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis	9
Mapping frameworks for synthesizing qualitative evidence in health technology assessment	9
Methods and criteria for the assessment of orphan drugs: a scoping review	9
Development and implementation of a value framework for rapid health technology assessment reports: enhancing evidence-informed decision making in resource-constrained settings	9
A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies	9
Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum	9
Health technology assessment in traditional and complementary medicine: a scoping review of international activity and examples of acupuncture	9
PP259 Invisible Resilience: The Value Of Medical Technology In Reducing Population And Health Systems’ Vulnerability To COVID-19.	8
Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review	8
PP165 Bridging The Gap Of Health Services During The COVID-19 Pandemic Through Telemedicine	8
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report	8
Acknowledgments	8
A model-based study to estimate the health and economic impact of health technology assessment in Thailand	8
PP09 Use Of Real-World Evidence For Managing Health Technologies Throughout The Life Cycle Of Transcatheter Aortic Valve Interventions	7
OP90 Optimizing Health Technology Assessment And Appraisal For Orphan Drug Reimbursement: Experiences And Tools For Improvement	7
Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect	7
PP149 A Multidimensional And Multistakeholder Approach: Assessing Ethical, Legal, Organizational, Social or Patient-centered (ELSI+) for Telemedicine In Neurological Diseases	7
OP181 Adapting Evidence To Produce A Health Technology Assessment Of Mammography Screening: An Example From The West Bank	7
The role of health economics within health technology assessment: past, present, and future – an Austrian perspective	7
PP118 Cyclic Mental Health Technology Assessment with Priority Setting And Involving Stakeholders - A Case Report From The Netherlands	7
A first exploration of the economic consequences of an autonomous surgical robot for lateral skull base surgery: an early health technology assessment	7
Acceptability of Manufacturer-Proposed Utility Values for NICE Cancer Medicine Appraisals: Analysis of Manufacturers’ Information Sources	7
PD203 Comparison Of Health Technology Assessment Methodologies Across Australia, Canada, New Zealand And The United Kingdom: Implications For Future Collaboration	6
PP09 Fecal Immunochemical Tests For Patients With Symptoms Suggestive Of Colorectal Cancer: A Systematic Review And Multiple-Threshold Meta-Analysis	6
OP176 Integrating Real-world Compliance In The Assessment Of Left Atrial Appendage Closure Versus Anticoagulation Therapy In Non-valvular Atrial Fibrillation	6
OP27 Impact Of Generic Entry Of Pharmaceuticals On Drug Prices In Australia	6
OP167 An Analysis Of Medication Exclusion Reports In The Health Technology Assessment Process For The Brazilian Unified Health System	6
OP80 Generating Patient Preference Evidence For Health Technology Assessment: A Sustainable Roadmap	6
OD11 Application Of Natural Language Processing To Predict Final Recommendation Of Brazilian Health Technology Assessment Reports	6
Economic evaluation of genomic/genetic tests: a review and future directions	6
OP46 The Decision Uncertainty Toolkit: Risk Measures And Visual Outputs To Support Health Technology Decision-making During Public Health Crises	6
Decision making for early surgical technology adoption into Canada’s healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities	6
PD71 Survival Outcomes And Adherence To Defined Daily Doses Of Imiglucerase: A 16-Year Brazilian Cohort Study In Gaucher Disease	6
Integrating organizational impacts into health technology assessment (HTA): an analysis of the content and use of existing evaluation frameworks	6
PP146 Seeing Eye-To-Eye on Real-World Evidence: Are Guidance from Japan and China Consistent with Recommendations from REALISE in Asia?	6
OP126 Clinical And Economic Evaluation Of The Effectiveness Of Cerebrolysin® In Neurological Patients With Post-Stroke Complications In Kazakhstan	6
Perception of non-layperson advisory committee members on the application of a discrete choice experiment instrument to patients and advisory committee members: a qualitative study	5
Results of health technology assessments of orphan drugs in Germany—lack of added benefit, evidence gaps, and persisting unmet medical needs	5
Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach	5
Health technology assessment and healthcare environmental sustainability: Prioritizing effort and maximizing impact	5

PP70 Mapping Of Health Technology Assessment In China: A Comparative Study Between 2016 And 2021	5
OP129 The Use Of A Text-Mining Screening Tool For Systematic Review Of Treatments For Relapsed/Refractory Diffuse Large B-Cell Lymphoma	5
Use of surrogate endpoints in health technology assessment: a review of selected NICE technology appraisals in oncology	5
A value framework for lymphoma therapies based on MACBETH method	5
A review of HTA guidelines on societal and novel value elements	5
OP51 Use Of Real-World Data In Cost-effectiveness Analysis Of Sequential Biologic Treatment For Rheumatoid Arthritis	5
Toward including environmental sustainability in Health Technology Assessment	5
The HTAi early HTA definition: a welcome milestone, and what must follow	5
The potential of the hospital-based Health Technology Assessment: Results of a world-wide survey	5
OP218 Searching Preprint Repositories For COVID-19 Therapeutics Using A Semi-Automated Text-Mining Tool	5
Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling	5
Value-based payment for high-cost treatments in Singapore: a qualitative study of stakeholders’ perspectives	4
OP163 Applying A Local Economic Evaluation Framework To Make Evaluations More Relevant For Local Decision Makers	4
OP136 A Comparison Of Health Technology Assessment Recommendations In Australia, Canada, And England: Is There Opportunity For Further Alignment?	4
OP44 Does The Health Economic Modelling Structure Matter? An External Validation Of Three Approaches Commonly Used In Obesity Modelling	4
OP105 Gaps, Challenges And Priorities For Neurodegenerative Disease Research And Health Technology Assessment	4
A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK	4
Optimizing red blood cell transfusion practices in the intensive care unit: a multi-phased health technology reassessment	4
PP111 Reimbursement And Payment Models: A Survey Of Stakeholders’ Current Experiences And Future Outlook Within The Dutch Policy Setting	4
PD05 Novel Non-Thermal Ablation Technology For The Treatment Of Atrial Fibrillation	4
Patient-based evidence: its role in decision making on end-of-life, orphan, and ultra-orphan medicines	4
OP199 From Pilot Studies To System-Wide Innovation: Challenges And Opportunities For Clinical Decision Support Systems (CDSS) Implementation In Australia	4
PD22 Exploratory Analysis of a Brazilian Real-World Open Database Applied to Prostate Cancer	4
OD39 Evaluation Of Sustainability And Environmental Impact Measures In Health Technology Assessment Of Medical Technologies In Europe: Starting An Important Journey	4
OP70 Implementation Of An Online Consultation Hub To Facilitate Consumer Engagement In Health Technology Assessment Processes	4
Patient perspectives on continuous glucose monitoring system (CGMS) for diabetes in Malaysia: a vital voice in health technology assessment (HTA) informing decision-making	4
A review of audiovisual telemedicine utilization and satisfaction assessment during the COVID-19 pandemic	4
Building capacity in horizon scanning, early awareness, and disinvestment: a framework for education and training	4
Acceptability of self-administered antigen test for COVID-19 in the Philippines	4
PD33 Development And Validation Of A Machine Learning-Based Prediction Model For COVID-19 Diagnosis Using Patients’ Metabolomic Profile Data	4
PP275 Incorporating Quality-Of-Care Indicators In Health Economic Modelling: A Case-Study On Surgical Site Infections In Cardiac Surgery	4
PP195 Cost Utility Of Transcatheter Aortic Valve Implantation For Patients With Inoperable Severe Aortic Stenosis In Brazil	4
OP65 An Overview Of Participatory Approaches, Stakeholders, Methods, Topics and Challenges In Medical Device Development: A Scoping Review	4
Analysis of consumer comments into PBAC decision-making (2014–9)	4
PD177 The Effect Of COVID-19 On Cancer Screening In Brazil, Canada, And The USA: A Cross-National Study	4
Advancing cooperation in Health Technology Assessment in Europe: insights from the EUnetHTA 21 project amidst the evolving legal landscape of European HTA	3
PD07 Cost-Effectiveness Of Direct Oral Anticoagulants In Chinese Patients With Non-Valvular Atrial Fibrillation	3
PD186 Treat-To-Target In Gout: Are Private General Practitioners In Malaysia Riding The Evidence-Based Wave?	3
PD124 Genicular Artery Embolization For The Treatment Of Knee Osteoarthritis: A Systematic Review And Meta-analysis	3
PP57 Outcomes Model For Assessing Strategies Improving In Vitro Fertilization Birth Rates	3
OD14 Harmonization Of HTA For Digital Health Technologies: The EU-Funded European Digital Health Technology Assessment Project	3
PP37 Guidance On Using Hospital-Based Real-World Evidence In Health Technology Assessments For Oncology	3
PP33 Molecular Markers For The Detection Of Clinically Significant Prostate Cancer	3
PP41 COVID-19 Modeling To Support Decision Making In Brazil: A Scoping Review	3
PD42 Should Antibiotics Be Used To Treat Recurrent Otitis Media In Children? Updating A Recommendation	3
PD231 A New Way Of Identifying And Selecting Health Technology Assessment Topics: Using Social Media And Citizen Involvement	3
PD199 Global Collaboration Post-Brexit: Do Project Orbis And The Access Consortium Improve Access In The UK Compared With Europe?	3
PD133 Exploring Real-World Data Based Financing Models For Lung Cancer Immunotherapy In The Czech Republic	3
Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum	3
PP120 Fluorescent In Situ Hybridization (FISH) Vs Conventional Cytogenetic (CC) For Detecting High-Risk Genetic Mutations In Multiple Myeloma	3
OP79 Incorporating Environmental Impacts Into Health Technology Assessment: An Examination Of Potential Approaches And Challenges	3
PP55 Health Technology Assessment Scoping Definition For Health Regulation	3
OP01 Impact Of Cost Heterogeneity On Assessing The Value Of Gene Therapies	3
PP34 Impact Of The COVID-19 Pandemic On Depression Incidence And Healthcare Service Use Among Patients With Depression	3
Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment	3
OP81 Do Sustainable Healthcare Principles Inform Guidance Development? An Exemplary Case Study In Respiratory Care	2
PP153 Efficacy And Safety of Onasemnogene Abeparvovec For The Treatment Of Patients With Spinal Muscular Atrophy Type 1: Meta-Analysis	2
PP14 Value-Based Pricing For Advanced Therapy Medicinal Products: Emerging Affordability Solutions	2
PP108 Multidimensional Analysis Of Peristeen Plus Medical Device	2
PD119 Interventions To Improve Long COVID Symptoms: A Systematic Review Of Randomized Controlled Trials	2
PP22 A Lifecycle Approach To The Use Of Real-World Evidence In HTA Submissions And Resubmissions: A Decade’s Experience	2
PD61 Thromboprophylaxis After Major Orthopedic Surgeries: Health Technology Assessment To Promote Access To Oral Anticoagulants	2
OP74 Analysis Of Literature And Research Foci In Overdiagnosis Based On Citespace	2
Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape	2
OP83 Joining Efforts To Improve Patient Involvement In Health Technology Assessment: The Case Of The RedETS Patient Interest Group	2
Expanding access to sodium-glucose cotransporter 2 inhibitors (SGLT2i) in the Ministry of Health Malaysia – a multiple HTA approach	2
PP87 Glecaprevir/pibrentasvir (Maviret®) Remains A Cost-effective Treatment For Chronic Hepatitis C Virus Infection After Changes To The Treated Population	2
PP222 Efficacy And Safety Of Foot Reflexology	2
PD50 Does The New Healthcare Reform Improve Job Satisfaction Among Village Clinic Doctors In China? A Meta-Analysis	2
IOATLAS: scanning across the medical horizon	2
OP98 Improving Patient Involvement In Health Technology Assessments: Is It Enough To Train Just The Patients?	2
PP100 Improving The Assessment Of Effectiveness For Digital Applications Using The B Statistic: Using WtsWrng As A Case Study	2
OP67 Considerations Of Treatment Novelty In Health Technology Assessment	2
PP53 Potential Cost-Effectiveness And Innovation Headroom Of A More Accurate Companion Diagnostic For PD-L1 In Non-Small-Cell Lung Cancer	2
Lifecycle evaluation of medical devices: supporting or jeopardizing patient outcomes? A comparative analysis of evaluation models	2
PD60 The Importance Of Systematic Reviews Addressing Questions Of Prevalence In Health Technology Assessment	2
Implementing a sandbox approach in health technology assessment: benefits and recommendations	2
OP13 Improving Case Finding For Celiac Disease In Children And Adults: Evidence Synthesis And Economic Modeling	2
PD96 Are Continuous Noninvasive Blood Pressure Monitoring Devices Accurate Enough To Replace Invasive Monitoring? A Rapid Review	2
OP244 Tools And Experiences To Facilitate Effective Patient Participation In Health Technology Assessment	2

PP129 Health Technology Assessment Adaptation: Pharyngolaryngeal Biopsies (OLB) For People with Suspected Head and Neck Cancer in the Outpatient Setting	2
Response to heterogeneity of tests and platforms in economic evaluations: synthetic model adoption; derivatives of transferable practice	2
The relative importance of severity and rarity criteria in health resource allocation: an umbrella review	2
OP83 Diagnostic Accuracy And Cost Effectiveness Of Automated Ankle Brachial Pressure Index Measurement For Peripheral Arterial Disease In People With Leg Ulceration	2
OP54 The Early Detection And Warning System ‘SINTESIS-New Technologies’: A Horizon Scanning Experience In Spain	2
PD32 Cost-Utility Of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres For Chemotherapy-Refractory Metastatic Colorectal Cancer In Brazil	2
PP109 Which Review Is Right For You? Choosing A Review Methodology	2
PD56 Conceptual Issues In The Valuation Of Health States In Children	2
OD30 Clinician-Driven Health Technology Assessment: National Cancer Medicines Review For Off-Label Uses And On-Label Off-Patent Uses In NHSScotland	2
OP31 Monitoring Of The Budget Impact Determinants Of Incorporated Technologies For Rare Diseases In The Brazilian Health System	2
OD33 Assessment Tool For MHealth Apps To Manage Depression (EvalDepApps Project)	2
Calibration of transition probabilities to model survival of adjuvant trastuzumab for early breast cancer in Indonesia	2
OP279 Data Protection In The European Union Post-General Data Protection Regulation (GDPR): A Barrier Or An Enabler Of Pharmaceutical Innovation?	2
OP69 Are Artificial-Intelligence-Based Literature Reviews Accepted By Health Technology Assessment Bodies?	2
PD24 Innovation In Chronic Obstructive Pulmonary Disease Care: Cost Effectiveness Of A New Self-Management Maintenance Program In The United Kingdom	1
PD32 Incorporating Environmental Factors Into Health Technology Assessment Submissions: A Scoping Review	1
OP39 Efficiency Frontier For Relapsing-Remitting Multiple Sclerosis In Brazil: An Approach To System Sustainability	1
PD35 A Decade In Review: Assessing The Quality Of Clinical Evidence For Oncology Drugs Submitted To A National Health Technology Assessment Agency	1
OP127 The Cost Effectiveness Of Anti-Vascular Endothelial Growth Factor Treatments For Age-Related Macular Degeneration In The Italian Healthcare Setting	1
PP85 The Cost-Effectiveness Of The Anti-COVID Vaccination Campaign In The Italian Healthcare Setting	1
A systematic literature review of revealed preferences of decision-makers for recommendations of cancer drugs in health technology assessment	1
OP35 Suitability Of Preference Methods Across The Medical Product Lifecycle: A Multicriteria Decision Analysis	1
OP06 Percutaneous Transforaminal Endoscopic Discectomy: From Insufficient Evidence To Reimbursement	1
European Network for Health Technology Assessment’s Response to COVID-19: Rapid Collaborative Reviews on Diagnostic Tests and Rolling and Rapid Collaborative Reviews on Therapeutics	1
OD26 Comparing Health Technology Developers’ Proposed Indication To An Estimated Indication Generated By An International Horizon Scanning Database	1
PP101 A Review Of Health State Utility Values Associated With Herpes Zoster	1
Increasing the impact of budget impact analysis: incorporating uncertainty for decision-makers in small markets	1
PP21 Examining Clinical Evidence: Incorporation Of Medications For Ultra-Rare Diseases – Descriptive Analysis Of Conitec Reports (2012 to 2022) – Brazil	1
PP71 Hospitalization Costs Associated With Advanced Non-Small Cell Lung Cancer In China: Real World Evidence From Jiangsu	1
PP231 Safety, Effectiveness And Economic Analysis Of Exercise Intervention For Prevention Of Cognitive And Functional Deterioration In Hospitalized Patients	1
Tisagenlecleucel for relapsed/refractory acute lymphoblastic leukemia in the Irish healthcare setting: cost-effectiveness and value of information analysis	1
PP103 Budget Impact Analysis Of Utilization Of WavelinQ Endo-arteriovenous Fistula System For Hemodialysis Patients: An Australian Hospital Perspective	1
Incorporating healthcare access and equity in economic evaluations: a scoping review of guidelines	1
OP61 Target Trial Emulation To Determine The Population-Level Cost-Effectiveness Of Multigene Panel Sequencing For Advanced Melanoma	1
OP93 The Cost Effectiveness Of Antiretroviral Therapy Adherence Interventions In HIV/AIDS Patients: A Systematic Review Of Decision Analytic Models	1
OD41 Conducting Systematic Reviews On Rare Diseases: Lessons Learned From The European Reference Networks Guidelines Programme	1
PP49 Cost Of Cardiac Implantable Electronic Device (CIED) Infections In Australia: A Private And Public Sector Payer Perspective	1
PP43 Budget Impact Analysis Of Next-Generation Sequencing Coverage In Taiwan’s National Health Insurance	1
PD168 Developing And Implementing A Value Framework For Rapid Health Technology Assessments: Enhancing Evidence-Informed Coverage In Resource-Constrained Settings	1
OP68 Adaptation Of Processes For HTA Of Digital Health Technologies Based On Artificial Intelligence	1
PD185 Is The Incorporation Of Medications For Ultrarare Diseases In Brazil Predominantly Driven By Costs? A Shift In Paradigm	1
PD226 Integration Of Patient And Clinician Insights Into The European Union Joint Scientific Consultations And Joint Clinical Assessments	1
PD90 Use Of Medicinal Herbs In Natura By Pregnant Women In The Amazon Region	1
PP99 Positron Emission Tomography Combined With Computed Tomography (PET/CT) Using 11-C Methionine (11C-MET)	1
PD18 Cytomegalovirus Prophylaxis With Valganciclovir For HIV-Immunosuppressed Patients: Cost Effectiveness And Budget Impact Analysis From The Brazilian Healthcare System Perspective	1
Priority setting for health technology adoption at the national level: Lessons learned over 25 years’ experience	1
PP81 Barriers To Implementation Of Health Technology Assessment	1
INAHTA member agency stories of engaging, adaptable, and impactful HTA	1
The UK early access to medicines scheme: uptake, approvals, and reimbursement	1
PP91 Developing A Re-assessment Process For Non-medicine Health Technologies In Wales	1
PP59 Do Patient Contributions Matter? A Thematic Document Analysis Of NICE Ultra-Rare Disease Appraisals	1
PP63 Perspectives Of Physical And Organic Disability Organizations On Health Technology Assessment Processes	1
National health technology assessment in Turkiye after a decade: are key principles followed?	1
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis	1
Values, principles, strategies, and frameworks underlying patient and public involvement in health technology assessment and guideline development: a scoping review	1
PP127 Early Health Technology Assessment (HTA) Of Medical Technologies To Inform Subsidy Decision-making In Singapore	1
PP106 Twenty Years Of Orphan Medicines Regulation: Have Treatments Reached Patients In Need Across Europe And Canada?	1
PP219 Combining Healthcare Solutions For Cataract Surgery. An Incremental Benefit Analysis From The Perspective Of The Russian Healthcare System	1
OP07 Eleven Years Of Conitec: Advances And Challenges Of Patient And Public Involvement In The Brazilian Health Technology Assessment Process	1
OP05 The Role Of Conditional Reimbursement In The Lifecycle Approach	1
OP248 A Minimum Data-Set For Left Ventricular Assist Device On Destination Therapy: Cross-Border Collaboration Pilot On Real World Data	1
Deliberative processes in decision making informed by health technology assessment in Latin America	1
PD155 RedETS Horizon Scanning: Impact In The Decision-Making Process	1
PP13 Cost-Effectiveness Analysis Of Antiandrogen Therapies For Metastatic Castration-Sensitive Prostate Cancer: The Brazilian Healthcare System Perspective	1
PD173 Semi-Automation Of Systematic Literature Review Title And Abstract Screening Using Text Mining And Classification Techniques	1
PP17 Navigating Health Technology Assessment (HTA) Requirements During Development Through Early HTA Scientific Advice: Insights From Companies’ Strategies, Challenges, And Priorities	1
PP03 Investigating Technological Strategies In The Hospital Setting: Insights From The Dutch Context	1
Transferability of a EUnetHTA relative effectiveness assessment to low- and middle-income countries setting	1
OP51 Improving Childhood Cancer Management And Financing In Ghana: Results From Stakeholder Mapping and Analysis	1
PD93 Uncertainty Metric To Guide PICOS Assessment And Evidence Synthesis Planning For Joint Clinical Assessment Submission	1
PP28 Is My Medicine Suitable For An Outcomes Based Agreement? The Feasibility Conundrum	1
PP140 Economic Evaluation Of Several Vaccination Strategies Against Rotavirus In Spain	1
OP45 Incorporation Of The Tetravalent Dengue Vaccine In The Brazilian Public Health System: A Cost–Benefit Analysis	1
PP38 Immersion in water during childbirth: A survey to the Spanish National Health System	1
OP115 Scoping Meta-Review On Methods Used To Assess Artificial Intelligence-Based Medical Devices For Heart Failure	1
OP34 Horizon Scanning A Matter Of Collaboration. A Description Of The Processes Of I-HTS Member Organizations	1
PD116 Development Of A Value Framework For The Appropriate Prescription Of High-Cost Cancer Drugs In A Cancer Center	1
OP74 Assessing Public Confidence Towards COVID-19 Vaccines Through Social Media Insights Leveraged Using Artificial Intelligence Techniques	1
OP56 Hospital-Based Health Technology Assessment: Barriers And Facilitators In France, Hungary, Italy, Kazakhstan, Poland, Switzerland, And Ukraine	1
OP47 New Health Technology Assessment Framework For Digital Health Technologies	1
PD25 Innovation In Facial Palsy Treatment: The Costs And Benefits Of Telerehabilitation Introduced Into Physical Therapy Pathways	1
PD26 Overscreening For Older Women In Cervical And Breast Cancer Screening In Japan	1
OP102 Towards Universal Health Coverage: Health Technology Assessment Roadmap Development In The Emirate Of Abu Dhabi Involving The Whole Ecosystem	1
OP93 Informing Efficient Diagnostic Monitoring Pathways Using Prospective Cohort Data: A Case Study In Neovascular Age-Related Macular Degeneration	1
OP94 Economic Evidence On Hemodialysis Access Creation Procedures In Patients With End-Stage Kidney Disease: A Systematic Literature Review	1
PP71 Lessons Learned During Analyses Of Appropriate Hearing Care: Building Bridges Between Patient Organizations, Health Professionals And Insurance Companies	1
Health technology assessment for oral health in the past decade: a scoping review	1
OP100 Patient Perspectives In Value Assessment Frameworks: The Asia Pacific Perspective	1
OP46 Assessing The Quality Of Pharmacoeconomic Evaluations About Type 2 Diabetes Mellitus Drugs In National Reimbursement Drug List	1
OD37 How The PICOTS-ComTeC Framework For Digital Health Interventions Can Be Useful For Health Technology Assessment	1
PD201 Rare Disease Product Approvals: The Changing Regulatory And Health Technology Assessment Landscape Between 2013 And 2022	1
OP35 Early Access To Medicinal Products In France: A Positive Evaluation Two Years Into The New Framework	1
PD225 Implementation Of Hospital-Based Health Technology Assessment For Innovative And Expensive Medical Devices In A French Teaching Hospital	1
PD179 Navigating Health Crises In Emerging Economies: A Comprehensive Examination Of COVID-19’s Influence On Health Care Access And Resilience	1
PD39 First Approach For Assessing Statistical Significance In Industry Funded Matching-Adjusted Indirect Comparison Studies: A Scoping Review	1